The Food and Drug Administration’s Advisory Committee on Wednesday approved expanding emergency use authorization for the Moderna and Pfizer-BioNTech vaccines for children from six months through 5 years old.
After the FDA makes a final decision, the Centers for Disease Control and Prevention will make its recommendation.